Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v5-FR | |
---|---|---|
Language | English | French |
Date Updated | 2022-09-27 | 2022-09-19 |
Drug Identification Number | 02298503 | 02298503 |
Brand name | DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP | DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP |
Common or Proper name | Diphenhydramine Hydrochloride Elixir USP | Diphenhydramine Hydrochloride Elixir USP |
Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
Ingredients | DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE |
Strength(s) | 12.5MG | 12.5MG |
Dosage form(s) | ELIXIR | ELIXIR |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 500 mL | 500 mL |
ATC code | R06AA | R06AA |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2022-09-16 | 2022-09-16 |
Estimated end date | 2022-10-07 | 2022-10-30 |
Actual end date | 2022-09-27 | |
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Product in allocation | Product in allocation |
Health Canada comments |